Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Vivos Therapeutics, Inc.

NASDAQ: VVOS · Industrial Applications and Services · 6 alerts · CIK 1716166

Share price
$0.0822Close, Nov 16
Market cap
$1.14M
Shares outstanding
13.89MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Vivos Therapeutics, Inc. filings on SEC EDGAR ↗

4:50 PM ET 8-K
M&A Deal

Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.

Vivos Therapeutics completed the acquisition of an 11% equity stake in SOD Sciences and a 50% co-ownership interest in SOD's pseudohypoxia early-warning test. The transaction was valued at $12 million, paid via the issuance of 12,000 shares of Series C Convertible Preferred Stock, and is expected to add over $10 million to Vivos' stockholders' equity.

Value
$12M
Counterparty
SOD Sciences, Inc.

“Today Vivos became more than a healthcare company just treating sleep apnea. We expect this transaction to add more than $10 million to our stockholders’ equity, and we now own half of a test designed to identify patients whose sleep apnea may be contributing to chronic disease.”

R. Kirk Huntsman, Chairman and Chief Executive Officer of Vivos

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.